Work

End-of-life (EOL) outcomes and healthcare utilization for patients with hepatocellular carcinoma (HCC) who received immune checkpoint inhibition (ICI).

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.4_suppl.560

Authors: Margaret Wheless, Anna-Carson Rimer Uhelski, Sarah Cimino, Henry Domenico, Sara F. Martin, Mohana Karlekar, Thatcher Heumann, Kristen Keon Ciombor, Laura Williams Goff, Rajiv Agarwal

Institutions: Vanderbilt University Medical Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center

Language: English

Topic: Palliative Care and End-of-Life Issues

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

Award: G9000075716

OpenAlex ID: W4406868869

Cites:

Cited by:

Related to: 10